CITIUS PHARMACEUTICALS INC (CTXR) Stock Cash Flow
NASDAQ:CTXR • US17322U3068
Current stock price
0.77 USD
-0.16 (-17.47%)
At close:
0.7599 USD
-0.01 (-1.31%)
After Hours:
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.85M | -39.74M | -39.43M | -32.54M | -33.64M | |||
| Depreciation Amortization | N/A | N/A | 1.40K | 2.70K | 0.00 | |||
| Income Taxes - Deferred | 1.06M | 1.06M | 576.00K | 576.00K | 580.00K | |||
| Change In Working Capital | -10.55M | 1.05M | -1.69M | -4.01M | 240.00K | |||
| Interest Paid | N/A | 187.40K | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 13.51M | 11.08M | 12.33M | 6.91M | 4.46M | |||
| OPERATING CASH FLOW | -34.84M | -26.55M | -28.20M | -29.06M | -28.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -5.75M | -5.00M | N/A | 0.00 | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | N/A | |||
| INVESTING CASH FLOW | N/A | -5.75M | -5.00M | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 1.00M | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 50.61M | 32.30M | 13.80M | 13.83M | 0.00 | |||
| Other Financing Activity | N/A | N/A | -3.83M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 51.61M | 33.30M | 9.97M | 13.83M | 0.00 | |||
| CHANGE IN CASH | 6.62M | 1.00M | -23.23M | -15.23M | -28.36M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -34.84M | -26.55M | -28.20M | -29.06M | -28.36M | |||
| Capital Expenditure | N/A | -5.75M | -5.00M | N/A | 0.00 | |||
| FREE CASH FLOW | -44.99M | -32.30M | -33.20M | -29.06M | -28.36M | |||
All data in USD